ACLARUBICIN for T-cell type acute leukaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where ACLARUBICIN was used for T-cell type acute leukaemia.
Most Reported Side Effects for ACLARUBICIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 80 | 25.5% | 3 | 20 |
| Bone marrow failure | 73 | 23.3% | 14 | 7 |
| Off label use | 38 | 12.1% | 6 | 4 |
| Nausea | 35 | 11.2% | 1 | 2 |
| Infection | 26 | 8.3% | 2 | 1 |
| Acute myeloid leukaemia | 24 | 7.6% | 11 | 8 |
| Product use in unapproved indication | 22 | 7.0% | 1 | 1 |
| Platelet count decreased | 21 | 6.7% | 5 | 9 |
| Febrile neutropenia | 19 | 6.1% | 8 | 5 |
| Pneumonia | 19 | 6.1% | 11 | 5 |
| Thrombocytopenia | 18 | 5.7% | 4 | 4 |
| Anaemia | 17 | 5.4% | 3 | 3 |
| Alopecia | 16 | 5.1% | 0 | 0 |
| Diarrhoea | 16 | 5.1% | 2 | 2 |
| Drug-induced liver injury | 16 | 5.1% | 2 | 0 |
Other Indications for ACLARUBICIN
Acute myeloid leukaemia (168)
Myelodysplastic syndrome (18)
Acute myeloid leukaemia refractory (15)
Chemotherapy (13)
Acute leukaemia (11)
Acute myeloid leukaemia recurrent (11)
Product used for unknown indication (9)
Myelodysplastic syndrome with excess blasts (8)
Acute promyelocytic leukaemia (7)
B-cell lymphoma (6)
Other Drugs Used for T-cell type acute leukaemia
VINCRISTINE (763)
METHOTREXATE (739)
CYTARABINE (520)
DEXAMETHASONE (452)
CYCLOPHOSPHAMIDE (436)
DAUNORUBICIN (367)
DOXORUBICIN (306)
PEGASPARGASE (297)
ASPARAGINASE (282)
MERCAPTOPURINE (251)